Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 476-670-7 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The test substance Fe(III)IDHA did not produce a significant increase of mutation frequency in strains Salmonella typhimurium TA 100, TA 98, TA 97, TA 1535, TA 102 up to the dose 5 mg/plate.Adequate positive and negative controls were performed and showed the reliability of the test system.The chelating agent IDHA (IDS)was investigated using the Salmonella/ microsome plate incorporation test for point mutagenic effects in doses of up to and including 5000 µg per plate on five Salmonella typhimurium LT2 mutants (OECD 471). In both experiment, evidence of mutagenic activity of IDS, Na-Salz was not seen. No biologically relevant increase in the mutant count, in comparison with the negative controls, was observed.
Therefore, the target substance Fe(Na)HBED is considered non-genotoxic.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Fe(III)IDHA Lot no. 906/P/Fe
Manufacturer code: 2415 Z
Productiondate: 14.09.2006
Fe: 9.0 % +/- 0.3 w/w - Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 97
- Species / strain / cell type:
- S. typhimurium TA 102
- Species / strain / cell type:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Metabolic activation system:
- The post-mitochondrial fraction (S9) fraction (batch MCH110406, protein content 69.2 mg/ml, Protocol 1/2006 and batch Aro 110406, protein content 76.5 mg/ml) were used. S9 was derived from livers of adult male rats.
- Test concentrations with justification for top dose:
- five concentration from range 0.01 - 5.0 mg/plate
The maximum dose 5 mg/plate was selecte d according OECD 471 guideline as the highest tested dose; this concentration was not toxic for all three strains TA 97, TA 1535 and TA 100. Because toxicity at the highest dose was not recognised (without reduced level of spontaneous mutations or reduction of bacterial lawn) in all next experiments the dose 5 mg/plate was the highest test dose. - Vehicle / solvent:
- steriledistilled water
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- Details on test system and experimental conditions:
- Test system
Salmonella typhimurium strains TA 100, TA 98, TA 97, TA 102 and TA 1535 from Czech
collection of microorganism (CCM) were used. From lyophilised cultures were prepared cultures long term maintained in liquid nitrogen; dimethylsulphoxide (DMSO) was used as cryoprotective agent. Suspension for test was prepared as ovemight culture from stock culture in liquid nitrogen. The tester strains were inoculated in nutrient broth (CASO broth, Merck) and incubated at 37°C for 18-20 hours to give the bacterial density of 108-109/ml.
Metabolic activation
The post-mitochondria] fraction (S9) fraction (batch MCHI 10406, protein content 69.2 mg/ml, Protocol 1/2006 and batch Aro 110406, protein content 76.5 mg/ml) were used. S9 was derived from livers of adult Sprague-Dawley małe rats (MAT CONSULTING, Slovakia), weighing approximately 200 g according to standard procedure (SOP 9). The animals were pre-treated with the agent 20-methylcholanthrene (admini stered i.p. at 80 mg/kg) or Aroclor 1254 (administere s i.p . at 500 mg/kg) 5 days prior to killing.
S9 fraction was stored in liquid nitrogen (-196°C) (SOP 1O).
S9 homogenate was diluted with cofactors (S9 MIX): 33 mM KCI, 8 mM MgC h , 5 mM glucose-6-phosphate, 4 mM NADP and 100 mM phosphate buffer (pH = 7,4). The S9 conc. in S9 MIX was 10%.
Positive control:
without activation - sodium azide: TA 1535, TA 100- 0.0015 mg/plate, 2-nitrofluoren e (2NF)-0.003 mg/plate: TA 98, 9-aminoacridine (9-AA)-0.075 mg/plate -TA 97 , mitomycin C: TA 102- 0.00025 mg/plate
with activation - 2-acetamidofluorene (2-AAF)- O. I 00 mg/plate
Safety manipulation with positive controls was performed according to standard procedure (SOP 10).
Negative control/solvent control: distilled water
Control of strains
Genotypes of each strain were confirmed based on the methods described by Maron and Ames (1983) prior to the mutagenicity study, which included requirement of histidine (his·), the sensitivity to crystal violet (rfa mutation) and UV light (uvrB mutation), and the resistance to ampicilin (R factor) and spontaneous revertant counts (protocols 1, 2, 3, 4, 5, 6/2007).
Chemicals
D-biotin (Serva), L-histidine (Serva), glucose (Merck), MgS04 (Mikrochem), NaCl (Mikrochem), KCl (Mikrochem), MgCh (Calbiochem), NaH2P0 4 . H20 (Mikrochem), Na2HP04 . 12H20 (Fluka), -nicotinamideadeninedinucleotid phosphate (NADP) (Sigma), glucoso-6- phosphate(G-6-P) (Sigma), ampicilin (Biotika), NaOH (Fluka), crystal violet (Serva), tetracycline (Biotika), sodium azide (Sigma), 9-aminoacr idine (Serva), 2- nitrofluorene (Aldrich), mitomycin C (Sigma), Aroclor 1254 (Analabs), 2 acetamidofluorene (Sigma), dimethylsulphoxide (Fluka), 20-methylcholanthrene (Sigma).
Instruments
Vortex minishaeker, water-bath, digital pH meter Sentron Titan (SOP 2), laboratory autoclave (CV-EL 10 I, CertoClav) ( SOP 3), semi aseptic box (Fatran)( SOP 4), biological incubator BT 102 (SOP 5), analytical weight HllO (Sartorius) and analytical weight OWA(SOP 6).
Media
Minimal agar containing Vogel-Bonner minimal medium and glucose ( SOPI) was used. Top agar contains 0.6% Bacto agar and 0.5% NaCI in distilled water, which was autoclaved and stored at room temperature. Before plating, 10 ml of sterile 0.5 mM histidine/0.5 mM
biotin solution was added to the meltened top agar, kept at 45°C and used as an overlay on the minimal agar plate.
CASO broth (Merck) was used for growing tester strains. The growth medium was stored at 2-8°C. Media were prepared according to standar d procedure (SOP 7).
Test performance Type of Salmonella assay
Tests were performed in compliance with OECD 471 (OECD, 1997) (3) according to standard procedure (SOP 1). This procedure evaluates the mutagenie potentia! of test chemicals by their effect on five histidine requiring strains of the bacterium, Salmonella typhimurium in the absence and presence of a rat liver metabolising system.
Range-finding assay
A preliminary range-finding assay was perfonned using three tested strains to determine the optima} non toxic test doses of Fe(III) IDHA. Fe(III) IDHA was freshly prepared in sterile distilled water and five concentrations from range O.Ol - 5.0 mg/plate were tested without metabolic activation. An aliquot of the culture was added to 2 ml of melten top agar, along with 0.1 ml of the test substance. The contents were then mixed and poured onto the surface of minimum agar plate. The plates were incubated at 37°C for 48 hours. After the incubation period, the number of revertant colonies per plate was counted.
Cultures were set up in triplicate; negative control and positive control were also included.
Protocol
Fresh cultures of bacteria at the late exponential or early stationary phase of growth (app. 109 cells per ml) at 37°C were exposed to the test substance in the presence and absence of metabolic activation system. 0.1 ml of the culture was added to 2 ml of melted top agar; along with O. I ml of the test agent. For the assay with metabolie activation, 0.5 ml of metabolic activation mixture containing 1O % of postmitochondrial fraction (S9) together with the bacteria and the test substance were used. The contents were then mixed and pored onto the surface of a minimum agar plate. The triplicate plates were used at each dose level.
All plates were incubated at 37°C for 48-72 hours. After the incubation period, the number of revertant colonies per plate was counted.
Treatment of results
Data were presented as the number of revertant colonies per plate. The mean numbers of revertants per plate and the standard deviations were presented for the test substance and positive and negative controls. - Evaluation criteria:
- Positive results: concentration -related increase over the tested range and reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation , Mp> 2. Student's t-test was used for evaluation of statistical significanceof mutation frequency increasing against solvent control value.
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 97
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Salmonella typhimurium TA 100 (Tables 2, 3. 12):
Four independent experiments were performed, two without metabolic activation, two with metabolie activation. The mean levels of spontaneous mutations were within range 151-231 revertants/plate.
In all experiments Fe(IJI) IDHA was tested in concentration range from O.Ol - 5.0 mg/plate (5 concentrations). The rate of number revertant colonies per plate and the level of revertant colonies in solvent control plates higher than 2 (MF > 2) was not observed.
In experiments without activation the level of revertant frequency was not significantly increased in comparison with negative (solvent) control. Positive control (sodium azide) induced statistic significant (p<0.01, 0.05) increase in revertant frequency under experimental conditions.
In experiments with metabolic activation the mutagenie potentia) ofFe(III) IDHA was confirmed neither in experiment s with S 9 fraction isolated from rat liver after induction with 20-methylcholanthrene nor in experiments with S 9 fraction isolated from rat liver after induction with Aroclor 1254. Positive response on the treatment with 2AAF showed ability of both S9 systems in activating of promutagens (statistic significant p<0.001).
Salmonella typhimurium TA 1535 (Tables 4,5,13):
Four independent experiments were realis e d, two without metabolic activation , two with metabolic activation. The mean level of spontaneous mutation was within range 6-29 revertants /plate. In all experiments, test article was tested in concentration range from O.Ol -
5.0 mg/plate (5 concentrations).
In experiments without metabolic activation the level of revertant frequency was not increased in comparison with negative (solvent) control. In the Exp #2 at the dose 0.5
mg/plate was observed statistically significant decrease of revertant number in comparison with negative (solvent) control but without biologica! sign ificance, MF < 2 (MF = 0.62). Po s itive control (sodium azide) induced statistic significant increase in revertant frequency (with statistical significance).
In experiment with S 9 prepared from rat liver induced with 20-methylcholanthrene was not detected mutagenie effect ofFe(III) IDHA; when the S9 was prepared from Aroclor 1254 induced rat liver the results were negative, too. In Exp #4 at the dose 1.0 mg/plate was observed statistically significant increase of revertant number in comparison with negative (solvent) control but without biologica! significance, Mp< 2 (MF= 1.43).
The ability of S9 systems to activate of promutagens was evaluated in each experiment with use of other Salmonella typhimurium strains (TA 100 and TA 98 with positive control 2AAF).
Salmonella typhimurium TA 97 (Tables 6,7,14):
Four independent experiments were performed, two without metabolic activation, two with metabolic activation. The mean level of spontaneous mutation was within range 139-245 revertants/plate. In all experiments Fe(III) IDHA was tested in concentration range from O.Ol to 5 mg/plate (5 concentrations).
In experiments without activation the level of revertant frequency was in one experiment at conc. 5.0 mg/plate statistically significant increased in comparison with negative (solvent) control but without biological significance, MF<2 (MF=1.13).
The result confirmed not mutagenie effect ofFe(III) IDHA under condition without activation. Positive control (9-aminoanthracene) induced statistic significant increase of revertant frequency.
The experiments with metabolic activation were performed with S 9 prepared from rat liver induced with 20-methylcholanthrene and with S 9 prepared from rat liver induced with Aroclor 1254. In experiment with metabolic activation the level ofrevertant frequency was not increased in comparison with negative (solvent) control up to a maxima! dose 5 mg/plate. The efficacy ofmetabolic activation was confirmed in activation of promutagens 2-AAF in experiment with Salmonella typhimurium TA 100, 98 realised under the some conditions.
Salmonella typhimurium TA 102 (Tables 8,9,15):
Four independent experiments were realised, three without metabolic activation, three with metabolic activation. The mean levels of spontaneous mutations were within range 252-364 revertants/plate. In all experiments Fe(III) IDHA was tested in concentration range from O.Ol to 5 mg/plate (5 concentrations).
In experiments without metabolic activation the level of revertant frequency was not increased in comparison with negative (solvent) control. Positive control (mitomycin C) induced statistic significant increase in revertant frequency (p<0.05 and p<0.001).
In experiments with metabolic activation the mutagenie potentia! offe(III) IDHA was confirmed neither in experiment with S 9 fraction isolated from rat liver after induction with 20-methylcholanthrene nor in experiment with S 9 fraction isolated from rat liver after induction with Aroclor 1254.
Positive response demonstrated the ability of the S9 systems to activate of promutagens was confirmed with positive control 2AAF on other Salmonella strains: TA 100 and TA 98.
Salmonella typhimurium TA 98 (Tables 10.11. 16):
Four independent experiments were realised, two without metabolic activation, two with metabolie activation. The mean level of spontaneous mutation was within range 15 53 revertants/plate.
In experiments without activation the level of revertant frequenc y was in one experiment at
conc. 5.0 mg/plate statistically significant increased in comparison with negative (solvent) control but without biologica! significance, MF< 2 (MF=1.43). It was not confirmed in the second experiment.
The result confirmed not mutagenie effect of Fe(III) IDHA under condition without activation. Positive control (2-nitrofluorene) induced statistic significant increase of revertant frequency (p<0.05 and p<0.001).
In experiments with metabolic activation the mutagenie potentia! ofFe(III) IDHA was confirmed neither in experiment with S 9 fraction isolated from rat liver after induction with 20-methylcholanthrene nor in exper iment with S 9 fraction isolated from rat liver after induction with Aroclor 1254. Positive response on the treatment with 2AAF showed ability of both S9 systems in activating of promutagens (statistic significant p<0.05 and p<0.01, MF
=15.5 and MF=40.8). - Conclusions:
- In the Ames test, with use offive strains of Salmonella typhimurium (TA 97, TA 98, TA 100, TA 102 and TA 1535) was tested Fe(III) TDHA with and without the addition of activation system (S9) for mutagenicit y in concentration range O.Ol - 5.0 mg/plate.
The Fe(III) IDHA produce neither a statistically significant dose-related increase in the number of revertants nor a statistically significant and reproducible positive response at any one of the test points and according these results is considerednon mutagenie in this system. - Executive summary:
Fe(III) IDHA was tested for mutagenie activity withSalmonella typhimuriumstrains TA 100, TA 98, TA97,TA1535 and TA102in bacterial reversemutation assay (Ames test) accordingtoOECD guideline 471 in compliance with GLP rules.
SubstanceFe(III)IDHAwasnottoxicuptoamaximumdose5.0mg/plateselectedaccording OECD 471 guideline as thehighesttested dose. Concentrations oftestcompound rangedbetweenO.Oland5.0mg/plate.
The test substance Fe(III) IDHA was evaluated formutagenicitywith use of Salmonella typhimurium strains TAlOO, TA98, TA 97, TA 1535 and TA102 in Ames standard plate assay without any modification in the absence of external metabolic activation, in standard plate assay without any modification. In experiments with the presence of extemal metabolic activation S9 fraction prepared from Sprague-Dawle y rat after induction with 20-methylcholanthrene and S9 fraction prepared from Sprague-Dawleyrat after induction with Aroclor1254 were used.
Adequate positive and negative controIs were performed and showed the reliability of the test system.
The test substance Fe(III)IDHA did not produce a significant increase in mutation frequency. at any tested concentration. It is concluded that does not exert mutagenie activity under the conditions of the test performed.
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1997-01-23 - 1997-07-17
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented GLP-guideline study
- Justification for type of information:
- Please see attached file.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5265 (The Salmonella typhimurium Bacterial Reverse Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his-
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- - Type and identity of media: normal nutrient broth
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: no data
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: no data
TA 1535 and TA 100 bear the base-pair substitution, his G 46, and TA 100 additionally contains the plasmid pKM 101.
This R factor, also contained in TA 98 and TA 102, codes for an ampicillin resistance and should raise the sensitivity of the strains.
TA 102 carries the ochre Mutation his G 428 on the multicopy plasmid pAQl, which codes in addition for tetracycline resistance.
TA 1537 and TA 98 bear frameshift markers.
TA 1537 exhibits the +1 mutant, his C 3076, while TA 98 bears the +2 type, his D 3052.
With the exception of TA 102, all strains have reduced capability to repair DNA-damage which increases the likelihood that such damage results in mutations. - Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- - Type and identity of media: normal nutrient broth
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: no data
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: no data
TA 1535 and TA 100 bear the base-pair substitution, his G 46, and TA 100 additionally contains the plasmid pKM 101.
This R factor, also contained in TA 98 and TA 102, codes for an ampicillin resistance and should raise the sensitivity of the strains.
TA 102 carries the ochre Mutation his G 428 on the multicopy plasmid pAQl, which codes in addition for tetracycline resistance.
TA 1537 and TA 98 bear frameshift markers.
TA 1537 exhibits the +1 mutant, his C 3076, while TA 98 bears the +2 type, his D 3052.
With the exception of TA 102, all strains have reduced capability to repair DNA-damage which increases the likelihood that such damage results in mutations. - Metabolic activation:
- with and without
- Metabolic activation system:
- the 9000 g fraction of homogenized mammalian Livers together with co-factors
- Test concentrations with justification for top dose:
- 0, 40, 158, 500, 1581 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionized water (formed a clear colourless solution
- the positive controls were dissolved in DMSO
- Justification for choice of solvent/vehicle: The solvent used was chosen out of the following solvents, in the order given: water, DMSO, methanol, ethanol, acetone, ethylene glycol dimethylether, and DMF according to information given by the internal sponsor. The order of these solvents is based on their bacteriotoxic effects in preincubation experiments. - Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- sodium azide (10 µg/plate, TA1535), nitrofurantoin (0.2 µg, TA100), 4-nitro-1,2-phenylene diamine (10 µg, TA1537), 4-nitro-1,2-phenylene diamine (0.5 µg/plate TA98), Cumene hydroperoxide (50 µg/plate) and 2-aminoanthracene (3 µg/plate, TA102)
- Positive control substance:
- sodium azide
- cumene hydroperoxide
- other: nitrofurantoin, 4-nitro-1,2-phenylene diamine, 2 aminoantracene
- Remarks:
- No "untreated" negative control was set up for the used solvent, since sufficient evidence was available ia the literature and from our own experience , indicating that this solvent had no influence on the spontaneous mutant counts of the used strains.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:in agar (plate incorporation)
For the mutant count, three plates were used, both with and without S9 mix, for each strain and dose. An equal number of plates, filled with the solvent minus the test substance, comprised the negative control. Each positive control also contained three plates per strain.
The amount of solvent for the test substance and for the controls was 0.1 mL/plate.
The doses for the first trial were routinely determined on the basis of a standard protocol: if not limited by solubility 5000 µg or 5 µL per plate were used as the highest dose. At least four, additional doses were routinely used. If less than three doses were used for assessment, at least two repeats were performed. The results of the first experiment were then considered as a pre-test for toxicity. However, in case of a positive response or if at least three doses could be used for assessment, the first trial was included in the assessment. If the second test confirmed the results of the first, no additional repeat was performed. Doses of repeats were chosen on the basis of the results obtained in the first experiment.
The first repeat was performed as preincubation in a water bath at 37°C for 20 minutes. At the end of the preincubation period 2 mL of molten soft agar were added to the tubes, the content mixed and plated.
For the mutant count, three plates were used for each strain and dose. An equal number of plates, filled with the solvent minus the test substance, comprised the negative control. Each positive-control also contained three plates per strain. In experiments without S9 mix buffer was used as replacement.
The dose of this trial were determined on the basis of the results of the plate incorporation assay. Doses are given as µg/tube for better separation of plate incorporation and preincubation trials, despite the fact that µg/plate and µg/tube could be used synonymously.
The toxicity of the substance was assessed in two ways. The first method was a gross appraisal of background growth on the plates for mutant determination. A reduction in background growth was indicated by the letter "b" after the mutant count and only a single "b", without any other values, is noted for a concentration, this "b" represents three plates with reduced background growth. Secondly, a toxic effect of the substance was assumed when there was a marked and dose-dependent reduction in the mutant count per plate, compared to the negative controls.
The bacterial suspensions were obtained from 17-hour cultures in nutrient broth, which had been incubated at 37°C and 90 rpm. These suspensions were used for the determination of mutant counts. No standardized procedure was employed to set the bacterial suspensions at a defined density of viable cells per milliliter, since the chosen method of incubation normally produces the desired density. However, the numbers of viable cells were established in a parallel procedure by determining the titers of the negative controls with S9 mix.
The dilution of bacterial suspensions used for the determination of titers was 1:1, 000, 000 . Titers were determined under the same conditions as were the mutations, except that the histidine concentration in the soft agar was increased fivefold to permit the complete growth of bacteria.
The tests were performed both with and without S9 mix.
The count was made after the plates had been incubated for 48 hours at 37°C. If no immediate count was possible, plates were temporarily stored in a refrigerator. - Evaluation criteria:
- The following criteria determined the acceptance of an assay:
a) The negative controls had to be within the expected range, as defined by published data and/or the laboratories' own historical data
b) The positive controls had to show sufficient effects, as defined by the laboratories' experience
c) Titer determinations had to demonstrate sufficient bacterial density in the suspension.
Only trials which complied with all three of the above criteria were accepted for assessment. Even if the criteria for points (b) and (c) were not met, a trial was accepted if it showed mutagenic activity of the test compound. Furthermore, an unacceptable trial would have been repeated. - Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- other: Due to the results of the first trial, doses ranging from 1000 µg to 5000 µg per tube were chosen for the repeat tests.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative without metabolic activation
negative with metabolic activation
Therefore, IDS, Na-Salz was considered to be non-mutagenic with and without S9 mix in the plate incorporation as well as in the preincubation modification of the Salmonella/microsome test. - Executive summary:
IDS, Na-Salz was investigated using the Salmonella/ microsome plate incorporation test for point mutagenic effects in doses of up to and including 5000 µg per plate on five Salmonella typhimurium LT2 mutants (Herbold, B, 1997a, OECD 471). These comprised the histidine-auxotrophic strains TA 1535, TA 100, TA 1537, TA 98 and TA 102. In a first experiment, doses up to and including 1581 µg per plate did not cause any bacteriotoxic effects. Total bacteria counts remained unchanged and no inhibition of growth was observed. At higher doses, the substance had only a weak, strain-specific bacteriotoxic effect. Due to the weakness of this effect this range could nevertheless be used for assessment purposes. Moreover, IDS, Na-Salz was investigated in an independent repeat using the Salmonella/microsome test for point mutagenic effects in doses up to 5000 µg per tube after preincubation for 20 minutes at 37°C on the same Salmonella typhimurium LT2 mutants. In this experiment, doses up to and including 5000 µg per tube did not cause any bacteriotoxic effects: Total bacteria counts remained unchanged and no inhibition of growth was observed.
In both experiment, evidence of mutagenic activity of IDS, Na-Salz was not seen. No biologically relevant increase in the mutant count, in comparison with the negative controls, was observed. The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, cumene hydroperoxide and 2-amino-anthracene had a marked mutagenic effect, as was seen by a biologically relevant increase in mutant colonies compared to the corresponding negative controls. Therefore, IDS, Na-Salz was considered to be non-mutagenic without and with S9 mix in the plate incorporation as well as in the preincubation modification of the Salmonella/microsome test.
Referenceopen allclose all
The colony number of each plate and mean values of the plate incorporation assay are listed for each dose in the tables 4 to 8, 13 and 14. As may be seen, there was no indication of a bacteriotoxic effect of IDS, Na-Salz at doses of up to and including 1581 µg per plate. The total bacteria counts consistently produced results comparable to the negative controls, or differed only insignificantly. No inhibition of growth was noted as well. 5000 µg/plate had only a weak, strain-specific bacteriotoxic effect. Therefore this dose could nevertheless be used for assessment purposes.
Salmonella typhimurium TA 102 revealed without S9 mix an in crease in mutant counts of about 80 as compared to the respective negative control (Table 5). This increase could not be confirmed (Tables 11 and 12), and is therefore to be regarded as a random result.
The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, cumene hydroperoxide and 2-amino-anthracene increased mutant counts to well over those of the negative controls, and thus demonstrated the system's sensitivity and the activity of the S9 mix.
The colony number of each plate and mean values of the preincubation assay are listed for each dose in Tables 6 to 10. As may be seen, there was no indication of a bacteriotoxic effect of IDS, Na-Salz at doses of up to and including 5000 µg per tube. The total bacteria counts consistently produced results comparable to the negative controls, or differed only insignificantly. No inhibition of growth was noted as well.
None of the five strains concerned showed a dose-related and biologically relevant increase in mutant counts over those of the negative controls (Tables 6 to 10) and thus confirmed the results of the plate incorporation method.
The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, cumene hydroperoxide and 2-amino-anthracene increased mutant counts to well over those of the negative controls, and thus demonstrated the system's sensitivity and the activity of the S9 mix.
| Table 2: Tabulated Summary of Data | ||||||
| Summary of Mean Values Without S9 Mix From Tables 1-12 | ||||||
| Table and group | Strain | |||||
| TA 1535 | TA 100 | TA 1537 | TA 98 | TA 102 | ||
| 1-5 | ||||||
| µ/plate | ||||||
| 0 | 6 | 97 | 9 | 22 | 151 | |
| 50 | 7 | 92 | 8 | 20 | 160 | |
| 158 | 6 | 90 | 9 | 17 | 149 | |
| 500 | 5 | 87 | 6 | 17 | 165 | |
| 1581 | 4 | 88 | 7 | 22 | 191 | |
| 5000 | 7 | 92 | 6 | 24 | 231 | |
| Na-azide | 924 | |||||
| NF | 209 | |||||
| 4-NPDA | 64 | 129 | ||||
| Cumene | 242 | |||||
| 6-10 | ||||||
| µg/tube | ||||||
| 0 | 7 | 127 | 8 | 21 | 315 | |
| 1000 | 7 | 125 | 9 | 28 | 325 | |
| 2000 | 6 | 128 | 7 | 29 | 327 | |
| 3000 | 6 | 98 | 6 | 31 | 304 | |
| 4000 | 7 | 136 | 4 | 32 | 255 | |
| 5000 | 6 | 122 | 5 | 18 | 265 | |
| Na-azide | 824 | |||||
| NF | 216 | |||||
| 4-NPDA | 69 | 171 | ||||
| Cumene | A.. | 599 | ||||
| 11-12 | ||||||
| µg/plate | ||||||
| 0 | 145 | 113 | ||||
| 1000 | 142 | 120 | ||||
| 2000 | 156 | 141 | ||||
| 3000 | 123 | 160 | ||||
| 4000 | 133 | 165 | ||||
| 5000 | 163 | 159 | ||||
| Cumene | 223 | 234 | ||||
| Table 3: Summary of Mean Values With S9 Mix From Tables 1-12 | ||||||
| Table and group | Strain | |||||
| TA 1535 | TA 100 | TA 1537 | TA 98 | TA 102 | ||
| 1-5 | ||||||
| µg/plate | ||||||
| 0 | 11 | 105 | 9 | 30 | 314 | |
| 50 | 13 | 96 | 14 | 26 | 271 | |
| 158 | 12 | 111 | 10 | 26 | 243 | |
| 500 | 9 | 104 | 8 | 33 | 295 | |
| 1581 | 7 | 122 | 8 | 25 | 265 | |
| 5000 | 12 | 119 | 8 | 25 | 332 | |
| 2-AA | 74 | 1675 | 91 | 2083 | 623 | |
| 6-10 | ||||||
| µg/tube | ||||||
| 0 | 6 | 104 | 6 | 26 | 353 | |
| 1000 | 5 | 105 | 5 | 24 | 357 | |
| 2000 | 7 | 98 | 6 | 26 | 384 | |
| 3000 | 8 | 108 | 5 | 29 | 380 | |
| 4000 | 5 | 108 | 6 | 22 | 381 | |
| 5000 | 6 | 95 | 6 | 21 | 404 | |
| 2-AA | 66 | 1227 | 26 | 1625 | 719 | |
| 11-12 | ||||||
| µg/plate | ||||||
| 0 | 196 | 159 | ||||
| 1000 | 174 | 181 | ||||
| 2000 | 161 | 183 | ||||
| 3000 | 168 | 151 | ||||
| 4000 | 188 | 154 | ||||
| 5000 | 178 | 156 | ||||
| 2-AA | 361 | 337 | ||||
| Bayer A.G. | Table : 4 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 13.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 1535 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 6 | 6 | 1 | 12 | 11 | 2 | 61 | 6.9 | 1.0 | 1.0 |
| 5 | 8 | 77 | ||||||||
| 7 | 12 | |||||||||
| 50 | 8 | 7 | 1 | 11 | 13 | 2 | % | / | 1.2 | 1.3 |
| 7 | 14 | |||||||||
| 7 | 15 | |||||||||
| 158 | 8 | 6 | 2 | 10 | 12 | 2 | % | / | 1.1 | 1.2 |
| 6 | 14 | |||||||||
| 5 | 13 | |||||||||
| 500 | 7 | 5 | 2 | 9 | 9 | 2 | % | / | 0.9 | 0.8 |
| 4 | 10 | |||||||||
| 5 | 7 | |||||||||
| 1581 | 5 | 4 | 1 | 7 | 7 | 1 | % | / | 0.7 | 0.7 |
| 4 | 7 | |||||||||
| 4 | 8 | |||||||||
| 5000 | 8 | 7 | 1 | 13 B | 12 | 1 | % | / | 1.2 | 1.2 |
| 6 | 11 B | |||||||||
| 7 | 13 B | |||||||||
| Na-azide 10 | 918 | 924 | 23 | % | / | / | % | / | 154. 1* | / |
| 905 | ||||||||||
| 950 | ||||||||||
| 2-AA 3 |
% | / | / | 77 | 74 | 5 | % | / | / | 6.9* |
| 68 | ||||||||||
| 77 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 5 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 13.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 100 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 106 | 97 | 9 | 102 | 105 | 3 | 42 | 5.0 | 1.0 | 1.0 |
| 89 | 106 | 58 | ||||||||
| 97 | 108 | |||||||||
| 50 | 86 | 92 | 7 | 90 | 96 | 7 | % | 0.9 | 0.9 | |
| 91 | 104 | |||||||||
| 100 | 95 | |||||||||
| 158 | 80 | 90 | 13 | 123 | 111 | 15 | % | / | 0.9 | 1.1 |
| 105 | 94 | |||||||||
| 86 | 116 | |||||||||
| 500 | 81 | 87 | 11 | 106 | 104 | 15 | % | / | 0.9 | 1.0 |
| 100 | 117 | |||||||||
| 81 | 88 | |||||||||
| 1581 | 99 | 88 | 10 | 126 | 122 | 4 | % | / | 0.9 | 1.2 |
| 84 | 118 | |||||||||
| 80 | 122 | |||||||||
| 5000 | 93 | 92 | 4 | 114 | 119 | 6 | % | / | 0.9 | 1.1 |
| 88 | 117 | |||||||||
| 95 | 126 | |||||||||
| NF 0.2 |
208 | 209 | 20 | % | / | / | % | / | 2.1* | / |
| 190 | ||||||||||
| 229 | ||||||||||
| 2-AA 3 |
% | / | / | 1785 | 1675 | 238 | % | / | / | 15.9* |
| 1838 | ||||||||||
| 1402 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 6 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 13.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 1537 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 8 | 9 | 1 | 7 | 9 | 2 | 88 | 8.9 | 1.0 | 1.0 |
| 9 | 9 | 89 | ||||||||
| 9 | 10 | |||||||||
| 50 | 8 | 8 | 1 | 13 | 14 | 1 | % | / | 0.9 | 1.6 |
| 7 | 14 | |||||||||
| 9 | 14 | |||||||||
| 158 | 8 | 9 | 1 | 12 | 10 | 2 | % | / | 1.0 | 1.2 |
| 8 | 9 | |||||||||
| 10 | 10 | |||||||||
| 500 | 9 | 6 | 3 | 10 | 8 | 2 | % | / | 0.7 | 0.9 |
| 6 | 7 | |||||||||
| 4 | 6 | |||||||||
| 1581 | 8 | 7 | 1 | 10 | 8 | 2 | % | / | 0.8 | 0.9 |
| 7 | 7 | |||||||||
| 6 | 6 | |||||||||
| 5000 | 7 | 6 | 1 | 7 | 8 | 2 | % | / | 0.7 | 0.9 |
| 6 | 10 | |||||||||
| 6 | 7 | |||||||||
| 4-NPDA 10 |
54 | 64 | 8 | % | / | / | % | / | 7.3* | / |
| 69 | ||||||||||
| 68 | ||||||||||
| 2-AA 3 |
% | / | / | 105 | 91 | 12 | % | / | / | 10.5* |
| 81 | ||||||||||
| 87 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 7 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 13.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 98 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 27 | 22 | 5 | 31 | 30 | 3 | 209 | 21.2 | 1.0 | 1.0 |
| 17 | 33 | 215 | ||||||||
| 23 | 27 | |||||||||
| 50 | 22 | 20 | 8 | 27 | 26 | 4 | % | / | 0.9 | 0.9 |
| 12 | 22 | |||||||||
| 27 | 29 | |||||||||
| 158 | 24 | 17 | 6 | 26 | 26 | 1 | % | / | 0.8 | 0.9 |
| 13 | 27 | |||||||||
| 14 | 26 | |||||||||
| 500 | 14 | 17 | 5 | 34 | 33 | 3 | % | / | 0.8 | 1.1 |
| 14 | 29 | |||||||||
| 23 | 35 | |||||||||
| 1581 | 19 | 22 | 3 | 25 | 25 | 2 | % | / | 1.0 | 0.8 |
| 24 | 27 | |||||||||
| 22 | 23 | |||||||||
| 5000 | 22 | 24 | 3 | 31 | 25 | 6 | % | / | 1.1 | 0.8 |
| 23 | 19 | |||||||||
| 28 | 24 | |||||||||
| 4-NPDA 0.5 |
138 | 129 | 8 | % | / | / | % | / | 5.8* | / |
| 127 | ||||||||||
| 122 | ||||||||||
| 2-AA 3 |
% | / | / | 1970 | 2083 | 103 | % | / | / | 68.7* |
| 2108 | ||||||||||
| 2172 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 8 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 13.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 102 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 151 | 151 | 6 | 302 | 314 | 15 | 68 | 6.0 | 1.0 | 1.0 |
| 145 | 309 | 52 | ||||||||
| 156 | 331 | |||||||||
| 50 | 169 | 160 | 17 | 254 | 271 | 15 | % | / | 1.1 | 0.9 |
| 140 | 278 | |||||||||
| 171 | 282 | |||||||||
| 158 | 168 | 149 | 17 | 247 | 243 | 6 | % | / | 1.0 | 0.8 |
| 141 | 245 | |||||||||
| 137 | 236 | |||||||||
| 500 | 175 | 165 | 9 | 258 | 295 | 35 | % | / | 1.1 | 0.9 |
| 164 | 301 | |||||||||
| 157 | 327 | |||||||||
| 1581 | 180 | 191 | 14 | 307 | 265 | 40 | % | / | 1.3 | 0.8 |
| 185 | 261 | |||||||||
| 207 | 228 | |||||||||
| 5000 | 269 | 231 | 33 | 350 | 332 | 17 | % | / | 1.5² | 1.1 |
| 211 | 329 | |||||||||
| 213 | 317 | |||||||||
| Cumene 50 |
249 | 242 | 17 | % | / | / | % | / | 1.6* | / |
| 222 | ||||||||||
| 254 | ||||||||||
| 2-AA 3 |
% | / | / | 629 | 623 | 14 | % | / | / | 2.0* |
| 607 | ||||||||||
| 634 | ||||||||||
| ² see Chapter 5.1 | *: Mutagenic effect | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 9 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 20.1997 | ||||||||
| AMES Test with IDS Na-salt | Strain: | S.typhimurium TA 1535 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 7 | 7 | 1 | 7 | 6 | 1 | 223 | 23.8 | 1.0 | 1.0 |
| 7 | 6 | 252 | ||||||||
| 6 | 6 | |||||||||
| 1000 | 7 | 7 | 2 | 5 | 5 | 1 | % | / | 1.0 | 0.8 |
| 8 | 5 | |||||||||
| 5 | 6 | |||||||||
| 2000 | 5 | 6 | 1 | 5 | 7 | 2 | % | / | 0.9 | 1.1 |
| 5 | 7 | |||||||||
| 7 | 8 | |||||||||
| 3000 | 6 | 6 | 2 | 7 | 8 | 1 | % | / | 1.0 | 1.2 |
| 5 | 9 | |||||||||
| 8 | 7 | |||||||||
| 4000 | 8 | 7 | 2 | 4 | 5 | 2 | % | / | 1.0 | 0.7 |
| 5 | 7 | |||||||||
| 7 | 3 | |||||||||
| 5000 | 6 | 6 | 0 | 5 | 6 | 2 | % | / | 0.9 | 0.9 |
| 6 | 5 | |||||||||
| 6 | 8 | |||||||||
| Na-azide 10 | 841 | 824 | 59 | % | / | / | % | / | 123.6* | / |
| 758 | ||||||||||
| 872 | ||||||||||
| 2-AA 3 |
% | / | / | 73 | 66 | 7 | % | / | / | 10.4* |
| 60 | ||||||||||
| 65 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
| Bayer A.G. | Table : 10 | Study Number: | T 5053854 | |||||||
| Department of Toxicology | Study Director: | Dr.Herbold | ||||||||
| Pharma Research Center | Technician: | Düver | ||||||||
| Wuppertal Elberfeld | Date: | Feb. 20.1997 | ||||||||
| AMES Test with : IDS Na-salt | Strain: | S.typhimurium TA 100 | ||||||||
| Dose/Plate (µg/Plate) | Revertants per plate | Titer | Quotient | |||||||
| 10% | Dilution per mL | |||||||||
| -S9 | M | SD | +S9 | M | SD | 10+6 | 10+8 | -S9 | +S9 | |
| Water | 135 | 127 | 7 | 105 | 104 | 2 | 197 | 19.7 | 1.0 | 1.0 |
| 124 | 102 | 196 | ||||||||
| 121 | 105 | |||||||||
| 1000 | 121 | 125 | 4 | 95 | 105 | 10 | % | / | 1.0 | 1.0 |
| 126 | 107 | |||||||||
| 128 | 114 | |||||||||
| 2000 | 138 | 128 | 9 | 108 | 98 | 12 | % | / | 1.0 | 0.9 |
| 125 | 101 | |||||||||
| 122 | 85 | |||||||||
| 3000 | 96 | 98 | 13 | 105 | 108 | 12 | % | / | 0.8 | 1.0 |
| 86 | 121 | |||||||||
| 111 | 97 | |||||||||
| 4000 | 126 | 136 | 17 | 118 | 108 | 12 | % | / | 1.1 | 1.0 |
| 126 | 110 | |||||||||
| 155 | 95 | |||||||||
| 5000 | 123 | 122 | 6 | 103 | 95 | 9 | % | / | 1.0 | 0.9 |
| 127 | 85 | |||||||||
| 115 | 97 | |||||||||
| NF 0.2 |
218 | 216 | 11 | % | / | / | % | / | 1.7* | / |
| 204 | ||||||||||
| 225 | ||||||||||
| 2-AA 3 |
% | / | / | 1219 | 1227 | 18 | % | / | / | 11.8* |
| 1248 | ||||||||||
| 1214 | ||||||||||
| *: mutagenic effect | B: Background lawn reduced | |||||||||
| %: not tested | SD: Standard-Deviation | |||||||||
| M: Mean | +S9: with S9 Mix | |||||||||
| -S9: without S9 Mix | ||||||||||
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Based on results of Ames Test performed with the target substance Fe(III)IDHA and chelating agents IDHA (IDS), the target substance Fe(III)IDHA does not need to be classified and labelled as genotoxic according to Regulation 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
